Pvs230D1-EPA/Matrix-M
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pvs230D1-EPA/Matrix-M, covering 2025-12-01 to 2025-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults [Phase 1]